Literature DB >> 17259330

Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects.

Melinda C Myzak1, Philip Tong, Wan-Mohaiza Dashwood, Roderick H Dashwood, Emily Ho.   

Abstract

Sulforaphane (SFN) is an isothiocyanate found in cruciferous vegetables such as broccoli. This anticarcinogen was first identified as a potent inducer of Phase 2 enzymes, but evidence is mounting that SFN acts through other cancer chemopreventive mechanisms. We recently reported on a novel mechanism of chemoprotection by SFN in human colon cancer cells and prostate epithelial cells, namely the inhibition of histone deacetylase (HDAC). In the present investigation, we sought to test whether SFN also might inhibit HDAC activity in vivo. When consumed in the diet at an average daily dose of 7.5 mumol per animal for 21 days, SFN suppressed the growth of human PC-3 prostate cancer cells by 40% in male nude mice. There was a significant decrease in HDAC activity in the xenografts, as well as in the prostates and mononuclear blood cells (MBC), of mice treated with SFN, compared to controls. There also was a trend towards increased global histone acetylation in the xenografts, prostates, and MBC. In human subjects, a single dose of 68 g BroccoSprouts inhibited HDAC activity significantly in peripheral blood mononuclear cells (PBMC) 3 and 6 hrs following consumption. These findings provide evidence that one mechanism through which SFN acts as a cancer chemopreventive agent in vivo is through the inhibition of HDAC activity. Moreover, the data suggest that HDAC activity in PBMC may be used as a biomarker for assessing exposure to novel dietary HDAC inhibitors in human subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259330      PMCID: PMC2267876     

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  44 in total

1.  Histone deacetylase and DNA methyltransferase in human prostate cancer.

Authors:  S K Patra; A Patra; R Dahiya
Journal:  Biochem Biophys Res Commun       Date:  2001-09-28       Impact factor: 3.575

Review 2.  Histone deacetylases and cancer: causes and therapies.

Authors:  P Marks; R A Rifkind; V M Richon; R Breslow; T Miller; W K Kelly
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

Review 3.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

4.  Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane.

Authors:  Carmela Fimognari; Michael Nüsse; Rossano Cesari; Renato Iori; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  Carcinogenesis       Date:  2002-04       Impact factor: 4.944

5.  Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.

Authors:  Victor Sandor; Susan Bakke; Robert W Robey; Min H Kang; Mikhail V Blagosklonny; Jonathon Bender; Rebecca Brooks; Richard L Piekarz; Eben Tucker; William D Figg; Kenneth K Chan; Barry Goldspiel; Antonio Tito Fojo; Stanley P Balcerzak; Susan E Bates
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

Review 6.  Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence.

Authors:  Alan R Kristal; Johanna W Lampe
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

Review 7.  Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.

Authors:  Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

8.  Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T lymphocytes.

Authors:  C Fimognari; M Nüsse; F Berti; R Iori; G Cantelli-Forti; P Hrelia
Journal:  Cell Mol Life Sci       Date:  2002-11       Impact factor: 9.261

9.  Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

Authors:  Wm Kevin Kelly; Victoria M Richon; Owen O'Connor; Tracy Curley; Barbara MacGregor-Curtelli; William Tong; Mark Klang; Lawrence Schwartz; Stacie Richardson; Eddie Rosa; Marija Drobnjak; Carlos Cordon-Cordo; Judy H Chiao; Richard Rifkind; Paul A Marks; Howard Scher
Journal:  Clin Cancer Res       Date:  2003-09-01       Impact factor: 12.531

10.  Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates.

Authors:  Y Zhang; T W Kensler; C G Cho; G H Posner; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

View more
  131 in total

Review 1.  Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.

Authors:  Stephanie M Tortorella; Simon G Royce; Paul V Licciardi; Tom C Karagiannis
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

Review 2.  Targeting the epigenome with bioactive food components for cancer prevention.

Authors:  Thomas Prates Ong; Fernando Salvador Moreno; Sharon Ann Ross
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-02-22

Review 3.  Dietary manipulation of histone structure and function.

Authors:  Emily Ho; Roderick H Dashwood
Journal:  World Rev Nutr Diet       Date:  2010-04-30       Impact factor: 0.575

4.  Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.

Authors:  Sujit Nair; Avantika Barve; Tin-Oo Khor; Guo-xiang Shen; Wen Lin; Jefferson Y Chan; Li Cai; Ah-Ng Kong
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

5.  Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells.

Authors:  Sonam Sinha; Samriddhi Shukla; Sajid Khan; Trygve O Tollefsbol; Syed M Meeran
Journal:  Mol Cell Endocrinol       Date:  2015-02-25       Impact factor: 4.102

6.  Inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: characterization, metabolism, and interconversion.

Authors:  Besma Abbaoui; Kenneth M Riedl; Robin A Ralston; Jennifer M Thomas-Ahner; Steven J Schwartz; Steven K Clinton; Amir Mortazavi
Journal:  Mol Nutr Food Res       Date:  2012-10-05       Impact factor: 5.914

7.  Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells.

Authors:  Huitao Fan; Rui Zhang; Dawit Tesfaye; Ernst Tholen; Christian Looft; Michael Hölker; Karl Schellander; Mehmet Ulas Cinar
Journal:  Epigenetics       Date:  2012-10-23       Impact factor: 4.528

Review 8.  Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention.

Authors:  Besma Abbaoui; Christopher R Lucas; Ken M Riedl; Steven K Clinton; Amir Mortazavi
Journal:  Mol Nutr Food Res       Date:  2018-08-29       Impact factor: 5.914

Review 9.  Nutritional genomics, polyphenols, diets, and their impact on dietetics.

Authors:  Stephen Barnes
Journal:  J Am Diet Assoc       Date:  2008-11

10.  Comparison of the effects of phenethyl isothiocyanate and sulforaphane on gene expression in breast cancer and normal mammary epithelial cells.

Authors:  Urvi Telang; Daniel A Brazeau; Marilyn E Morris
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.